Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Oxygen therapy subsides abnormal movements in a rare childhood disease

Published on: 21/02/2023 Reading time: 1 min
image neurones corticaux
Retour à la recherche

Researchers led by Emmanuel Flamand-Roze, at Paris Brain Institute, have shown that a simple administration of oxygen can alleviate abnormal movement attacks in an orphan disease – alternating hemiplegia of childhood (AHC). These encouraging preliminary results are published in Movement Disorders.

Alternating hemiplegia is a severe neurodevelopmental disorder associated with a mutation in the ATP1A3 gene. It begins in early childhood, causing symptoms that significantly impair quality of life. Young patients are affected by episodes of paralysis which can last from a few minutes to several days and involve one or alternating sides of the body. They also experience repetitive muscle contractions called dystonia, which sometimes last for hours and are often painful.

Pharmacological treatment is usually ineffective. For the time being, disease management is based on the administration of sedatives because symptoms completely disappear upon sleep. Avoiding events that can trigger hemiplegic and dystonic attacks – such as stress or physical exertion – sometimes allows acute episodes to be spaced out.

We don’t know how to help these patients. Therefore, we remain particularly attentive to the sometimes-unexpected factors that could relieve them. Recently, a 25-year-old man told us that after receiving laughing gas during an episode of dystonia, his symptoms subsided within minutes. We tried to identify the reason, knowing that this gas – nitrous oxide – is usually administered with 50% oxygen. As it is impossible to give nitrous oxide in daily treatment, we wanted to test whether oxygen was responsible for stopping the attack.

Emmanuel Flamand-Roze Neurologist and expert in abnormal movements

The researchers then installed an oxygen therapy device in the patient's home. “We observed that dystonic attacks stopped 15 minutes after the oxygen was administered,” says the researcher. This is a significant benefit, as this young man could experience up to 8 episodes a day, some of which could last several hours. His quality of life was improved. Oxygen therapy is a safe, highly accessible treatment that can significantly reduce the use of potent sedatives, such as midazolam, which the patient was taking at a rate of 40 doses per month.”

Team member Quentin Welniarz proposed a hypothesis to explain the effect of oxygen. According to him, a phenomenon called cortical spreading depression (CSD), which corresponds to a wave of electrical disturbance in the brain, plays an essential role in triggering the symptoms of alternating hemiplegia. This wave consists of a rapid phase of neuronal hyperactivity and a slower phase of electrical silence in the cortex cells. It’s also associated with hypoxia – i.e., reduced oxygen availability. Rapid administration of oxygen at the time of attacks could therefore interrupt or mitigate this phenomenon.

To ensure that the association between oxygen delivery and mitigation of dystonia attacks is not coincidental, researchers must ensure that the same effect occurs in other patients under comparable conditions. Similarly, it remains to be clarified how to optimize the use of oxygen therapy, especially at home, so that it is as little restrictive as possible.

Sources

Welniarz, Q. et al. Oxygen therapy: an acute treatment for paroxysmal dystonia in alternating hemiplegia of childhood. Movements Disorders. DOI: 10.1002/mds.29357.

Our news on the subject

TDAH : les troubles de l’attention sont associées à l’intrusion d’ondes du sommeil pendant l’éveil
ADHD: Attention difficulties are linked to the intrusion of sleep waves during wakefulness
Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...
03.17.2026 Research, science & health
L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
See all our news